Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
18.6M
-
Shares change
-
-41.5K
-
Total reported value, excl. options
-
$955M
-
Value change
-
-$1.82M
-
Put/Call ratio
-
16
-
Number of buys
-
84
-
Number of sells
-
-72
-
Price
-
$51.47
Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2023
194 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q1 2023.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.6M shares
of 22.5M outstanding shares and own 82.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.21M shares), Conestoga Capital Advisors, LLC (1.85M shares), VANGUARD GROUP INC (1.47M shares), Copeland Capital Management, LLC (1.36M shares), Ranger Investment Management, L.P. (990K shares), GENEVA CAPITAL MANAGEMENT LLC (907K shares), STATE STREET CORP (746K shares), DIMENSIONAL FUND ADVISORS LP (664K shares), GEODE CAPITAL MANAGEMENT, LLC (403K shares), and CRAMER ROSENTHAL MCGLYNN LLC (376K shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.